These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The specific immunotherapy of autoimmune diseases through the nanomedicine. Verdaguer J Endocrinol Nutr; 2016 Nov; 63(9):437-439. PubMed ID: 27344428 [No Abstract] [Full Text] [Related]
3. Autoimmune endocrine diseases. De Baets MH Year Immunol; 1989; 4():264-75. PubMed ID: 2564710 [No Abstract] [Full Text] [Related]
4. Pathogenesis of type I (insulin-dependent) diabetes: possible mechanisms of autoimmune damage. Bottazzo GF; Bosi E; Bonifacio E; Mirakian R; Todd I; Pujol-Borrell R Br Med Bull; 1989 Jan; 45(1):37-57. PubMed ID: 2529018 [TBL] [Abstract][Full Text] [Related]
5. Possible chronological events leading to pancreatic beta cell damage in type I diabetes mellitus. Bottazzo GF; Bosi E Ann Ital Med Int; 1988; 3 Suppl 1():53-9. PubMed ID: 2978955 [No Abstract] [Full Text] [Related]
6. [1990 Apollinaire Bouchardat Prize. Immunology of insulin-dependent diabetes mellitus: in vitro and in vivo study models in animals]. Boitard C Journ Annu Diabetol Hotel Dieu; 1990; ():285-99. PubMed ID: 2195212 [No Abstract] [Full Text] [Related]
7. Mechanisms of help and suppression in the AMLR: studies in normal and NZB mice. Smith JB; Wolos JA; Bocchieri MH Behring Inst Mitt; 1983 May; (72):37-46. PubMed ID: 6242339 [No Abstract] [Full Text] [Related]
8. Immunomodulation of experimental allergic encephalomyelitis by antibodies to the antigen-Ia complex. Aharoni R; Teitelbaum D; Arnon R; Puri J Nature; 1991 May; 351(6322):147-50. PubMed ID: 1709449 [TBL] [Abstract][Full Text] [Related]
9. Type-I diabetes: a chronic autoimmune disease of human, mouse, and rat. Castaño L; Eisenbarth GS Annu Rev Immunol; 1990; 8():647-79. PubMed ID: 2188676 [No Abstract] [Full Text] [Related]
10. [Aberrant expression of HLA-DR antigens and autoimmune phenomenon in endocrine diseases]. Gutiérrez C; Fernández-Cruz E Rev Clin Esp; 1986 Apr; 178(6):255-8. PubMed ID: 3487815 [No Abstract] [Full Text] [Related]
14. Faulty major histocompatibility complex class I function linked to autoimmune diabetes. Faustman D Transplant Proc; 1992 Dec; 24(6):2874-6. PubMed ID: 1465979 [No Abstract] [Full Text] [Related]
15. Antigen recognition and peptide-mediated immunotherapy in autoimmune disease. Smilek DE; Lock CB; McDevitt HO Immunol Rev; 1990 Dec; 118():37-71. PubMed ID: 1706681 [No Abstract] [Full Text] [Related]
16. Spontaneous T-cell proliferation in the non-obese diabetic mouse to a peptide from the unique class II MHC molecule, I-Ag7, which is also protective against the development of autoimmune diabetes. Xu XJ; Gearon C; Stevens E; Vergani D; Baum H; Peakman M Diabetologia; 1999 May; 42(5):560-5. PubMed ID: 10333048 [TBL] [Abstract][Full Text] [Related]
17. The class II MHC I-Ag7 molecules from non-obese diabetic mice are poor peptide binders. Carrasco-Marin E; Shimizu J; Kanagawa O; Unanue ER J Immunol; 1996 Jan; 156(2):450-8. PubMed ID: 8543793 [TBL] [Abstract][Full Text] [Related]
18. Nanoparticles for the induction of antigen-specific Tregs. Quintana FJ Immunotherapy; 2013 May; 5(5):437-40. PubMed ID: 23638737 [No Abstract] [Full Text] [Related]